Intracoronary Injection of Autologous CD34+ Cells Improves One-Year Left Ventricular Systolic Function in Patients With Diffuse Coronary Artery Disease and Preserved Cardiac Performance—A Randomized, Open-Label, Controlled Phase II Clinical Trial
Journal of Clinical Medicine
doi 10.3390/jcm9041043
Full Text
Open PDFAbstract
Available in full text
Date
April 7, 2020
Authors
Publisher
MDPI AG